Results 161 to 170 of about 184,779 (275)

How best to capture the impact of complementary therapies in palliative care: A systematic review to identify and assess the appropriateness and validity of multi-domain tools. [PDF]

Palliat Med, 2022
Mitchinson L, Chu C, Bruun A, Sisk AR, Armstrong M, Vindrola-Padros C, Kupeli N, Candy B, Stone P.   +8 more
europepmc   +1 more source

Class IIa HDACs forced degradation allows resensitization of oxaliplatin‐resistant FBXW7‐mutated colorectal cancer

Molecular Oncology, EarlyView.
HDAC4 is degraded by the E3 ligase FBXW7. In colorectal cancer, FBXW7 mutations prevent HDAC4 degradation, leading to oxaliplatin resistance. Forced degradation of HDAC4 using a PROTAC compound restores drug sensitivity by resetting the super‐enhancer landscape, reprogramming the epigenetic state of FBXW7‐mutated cells to resemble oxaliplatin ...
Vanessa Tolotto, Nicolò Gualandi, Ylenia Cortolezzis, Raffaella Picco, Monica Colitti, Francesca D'Este, Mariachiara Gani, Wayne W. Hancock, Giovanni Terrosu, Cristina Degrassi, Francesca Agostini, Claudio Brancolini, Luigi E. Xodo, Eros Di Giorgio   +13 more
wiley   +1 more source

Complementary therapies for the management of attention deficit hyperactivity disorder in children: a scoping review. [PDF]

Rev Lat Am Enfermagem
Szychta LF, Sombra SEL, Lima GA, Ventura MWS, Oliveira BSB, Lima FET.   +5 more
europepmc   +1 more source

Current Status of Complementary Therapies Provided by Hospice Palliative Care in South Korea. [PDF]

J Hosp Palliat Care, 2021
Kwon S, Bak J, Kwon SH.
europepmc   +1 more source

Dual targeting of RET and SRC synergizes in RET fusion‐positive cancer cells

Molecular Oncology, EarlyView.
Despite the strong activity of selective RET tyrosine kinase inhibitors (TKIs), resistance of RET fusion‐positive (RET+) lung cancer and thyroid cancer frequently occurs and is mainly driven by RET‐independent bypass mechanisms. Son et al. show that SRC TKIs significantly inhibit PAK and AKT survival signaling and enhance the efficacy of RET TKIs in ...
Juhyeon Son, Lily L. Remsing Rix, Bin Fang, Eric A. Welsh, Nicole V. Bremer, Valentina Foglizzo, Paola Roa, Nickole Sigcha‐Coello, Yi Liao, Eric B. Haura, Alexander Drilon, John M. Koomen, Emiliano Cocco, Uwe Rix   +13 more
wiley   +1 more source

Integrative Approaches to Ovulation Induction in Polycystic Ovary Syndrome: A Narrative Review of Conventional and Complementary Therapies. [PDF]

Biomedicines
Song SY.
europepmc   +1 more source

Molecular characterisation of human penile carcinoma and generation of paired epithelial primary cell lines

Molecular Oncology, EarlyView.
Generation of two normal and tumour (cancerous) paired human cell lines using an established tissue culture technique and their characterisation is described. Cell lines were characterised at cellular, protein, chromosome and gene expression levels and for HPV status.
Simon Broad, Mahmood Hachim, Tom Bertin, Karolina Penderecka, Rifat Hamoudi, Saif Khan, Rui Henrique, Natalie Bergmoser, Manit Arya, Kalle Sipila, Matteo Vietri Rudan, Asif Muneer, Aamir Ahmed   +12 more
wiley   +1 more source

Development of a core outcome set for the trials of complementary therapies in people with multiple sclerosis: international survey and consensus meetings. [PDF]

BMJ Open
Lopez-Alcalde J, Tietjen AK, Yan Y, Canella C, Barth J, Steinemann N, Hägele-Link S, Bolt S, Baum C, Rettenmund G, von Wyl V, Nonino F, Wieland LS, Wang X, Schmick A, Pagnini F, Kesselring J, Khazaei H, Pérez-Neri I, Studer-Merkle U, Witt CM.   +20 more
europepmc   +1 more source

Factors associated with the use of complementary therapies in Taiwanese patients with systemic lupus erythematosus: a cross-sectional study. [PDF]

BMC Complement Med Ther, 2021
Lu MC, Lo HC, Chang HH, Hsu CW, Koo M.
europepmc   +1 more source

Data for: "Enrichment Sessions as a Complementary Therapy for Hospitalized Cats: Implications for Stress Reduction and Sporotrichosis’ Lesion Recovery"

, 2023
Sabrina Tiemi Morais Sato, Ruan R. Daros
openalex   +1 more source